News
- Author:
- Dan Watson
Publish date: July 6, 2017
It is more important than ever to establish the long-term safety of fecal microbiota transplantation.
News
- Author:
- Dan Watson
Publish date: June 22, 2017
A study of adults provides evidence linking dietary carbohydrate consumption to acne.
News
- Author:
- Dan Watson
Publish date: June 8, 2017
A meta-analysis of 31 studies addresses the controversial issue: Does isotretinoin therapy increase the risk of depression in patients with acne?
News
- Author:
- Dan Watson
Publish date: June 3, 2017
Talk to patients who might be traveling to regions where malaria is endemic about taking chemoprophylaxis.
News
- Author:
- Dan Watson
Publish date: May 11, 2017
Survival of persons with HIV-1 infections taking ART continues to improve.
News
- Author:
- Dan Watson
Publish date: April 24, 2017
EnterobacteriaceaeE. cloacae
News
- Author:
- Dan Watson
Publish date: April 20, 2017
A study of 285 clinically depressed older people finds a longitudinal association between physical frailty and the course of depression.
News
- Author:
- Dan Watson
Publish date: April 3, 2017
CDC study supports “current recommendations for annual influenza vaccination for all children” aged 6 months and older.
News
- Author:
- Dan Watson
Publish date: March 29, 2017
The FDA designation is based on the results of a recently published French study.
News
- Author:
- Dan Watson
Publish date: March 29, 2017
Childhood obesity and overweight have implications for adult liver disease.
News
- Author:
- Dan Watson
Publish date: March 1, 2017
Can rotavirus and PCV vaccines affect more than the diseases they target?
News
- Author:
- Dan Watson
Publish date: March 1, 2017
Could tissue and peripheral eosinophilia be markers of pediatric UC?
News
- Author:
- Dan Watson
Publish date: February 23, 2017
Higher risks of schizophrenia and affective disorders are tied to infections treated with anti-infective agents, an examination of the health recor...
News
- Author:
- Dan Watson
Publish date: February 22, 2017
Since ERCP has risks, a group of tests can better predict who should receive it.
News
- Author:
- Dan Watson
Publish date: February 9, 2017
Emflaza (deflazacort) becomes the first corticosteroid to be approved by the Food and Drug Administration for Duchenne muscular dystrophy.
